Cormorant Asset Management, LP Cytokinetics Inc Transaction History

Cormorant Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $4.01 Million - $5.67 Million	-104,000 Reduced 26.0%	296,000 $14.3 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $8.92 Million - $13.8 Million	-300,000 Reduced 42.86%	400,000 $14.7 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $10.3 Million - $13.9 Million	-300,000 Reduced 30.0%	700,000 $31.9 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $18.5 Million - $35.7 Million	1,000,000 New	1,000,000 $35.7 Million

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.